spot_img
27.8 C
London
HomeTOP STORIESHalozyme raises 2025 guidance to $1.3B–$1.375B revenue driven by royalty momentum and...

Halozyme raises 2025 guidance to $1.3B–$1.375B revenue driven by royalty momentum and expands with Elektrofi acquisition

Post Content 

spot_img

latest articles

explore more